Aluminum, Alzheimer's disease and the geospatial occurrence of similar disorders

Reviews in Mineralogy and Geochemistry

Volumn 64, Issue , 2006, Pages 115-134

  Perl, Daniel P ^a   Moalem, Sharon ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846018079     PISSN: 15296466     EISSN: None     Source Type: Book Series    
DOI: 10.2138/rmg.2006.64.4     Document Type: Review

References (96)

1. Ahlskog JE, Waring SC, Kurland LT, Petersen RC, Moyer TP, Harmsen WS, Maraganore DM, O'Brien PC, Esteban-Santillan C, Bush V (1995) Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis. Neurology 45:1340-1344
2. Arnold A, Edgren DC, Palladino VS (1953) Amyotrophic lateral sclerosis. Fifty cases observed on Guam. J Nerv Ment Dis 117:135-139
3. Bomford A (2002) Genetics of haemochromatosis. Lancet 360:1673-1681
4. Bridelli MG, Tampellini D, Zecca L (1999) The structure of neuromelanin and its iron binding site studied by infrared spectroscopy. FEBS Lett 457:18-22
5. Buee-Scherrer V, Buee L, Hof PR, Leveugle B, Gilles C, Loerzel AJ, Perl DP, Delacourte A (1995) Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: immunochemical characterization of tau proteins. Am J Pathol 68:924-932
6. Candy JM, Oakley AE, Klinowski J, Carpenter TA, Perry RH, Atack JR, Perry EK, Blessed G, Fairbairn A, Edwardson JA (1986) Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet 1: 354-357
7. Castellani RJ, Perry G, Siedlak SL, Nunomura A, Shimohama S, Zhang J, Montine T, Sayre LM, Smith MA (2002) Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans. Neurosci Lett 319:25-28
8. Chen KM, Makifuchi T, Garruto RM, Gajdusek DC (1982) Parkinsonism-dementia in a Filipino migrant: a clinicopathologic case report. Neurology 32:1221-1226
9. Crapper DR, Krishnan SS, Dalton AJ (1973) Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 180:511-513
10. Crapper DR, Krishnan SS, Quittkat S (1976) Aluminum, neurofibrillary degeneration and Alzheimer's disease. Brain 99:67-80
11. Datz C, Haas T, Rinner H, Sandhofer F, Patsch W, Paulweber B (1998) Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: a protective role against iron deficiency? Clin Chem 44:2429-2432
12. Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 52:1830-1836
13. Double KL, Gerlach M, Schunemann V, Trautwein AX, Zecca L, Gallorini M, Youdim MB, Riederer P, Ben-Shachar D (2003) Iron-binding characteristics of neuromelanin of the human substantia nigra. Biochem Pharmacol 66:489-494
14. Drayer BP (1989) Magnetic resonance imaging and extrapyramidal movement disorders. Eur Neurol 29 Suppl 1:9-12
15. Earle KM (1968) Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. J Neuropathol Exp Neurol 27:1-14
16. Eijkelkamp EJ, Yapp TR, Powell LW (2000) HFE-associated hereditary hemochromatosis. Can J Gastroenterol 14:121-125
17. Eldridge R, Ryan E, Rosario J, Brody JA (1969) Amyotrophic lateral sclerosis and parkinsonism-dementia in a migrant population from Guam. Neurology 19:1029-1037
18. Enochs WS, Sarna T, Zecca L, Riley PA, Swartz HM (1994) The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis. J Neural Transm Park Dis Dement Sect 7:83-100
19. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr., Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408
20. Fodinger M, Sunder-Plassmann G (1999) Inherited disorders of iron metabolism. Kidney Int Suppl 69:S22-S34
21. Gajdusek DC (1963) Motor neuron disease in natives of New Guinea. N Engl J Med 268:474-476
22. Gajdusek DC (1982) Foci of motor neuron disease in high incidence in isolated populations of East Asia and the Western Pacific. In: Human Motor Neuron Disease. Rowland LP (ed) Raven Press, p 363-393
23. Gajdusek DC (1984) Calcium deficiency induced secondary hyperparathyroidism and resultant CNS deposition of calcium and other metallic cations as the cause of ALS and PD in high incidence among the Auyu and Jakai people in west New Guinea. In: Amyotrophic Lateral Sclerosis in Asia and Oceania. Chen KM, Yase Y (eds) Shyan-Fu Chou National Taiwan University, Taipei, p 145-171
24. Galasko D, Salmon DP, Craig UK, Thal LJ, Schellenberg G, Wiederholt W (2002) Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000. Neurology 58:90-97
25. Garruto RM, Fukatsu R, Yanagihara R, Gajdusek DC, Hook G, Fiori C (1984) Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam. Proc Natl Acad Sci USA 81:1875-1879
26. Garruto RM, Gajdusek DC, Chen KM (1981) Amyotrophic lateral sclerosis and parkinsonism-dementia among Filipino migrants to Guam. Ann Neurol 10:341-350
27. Garruto RM, Yanagihara R, Gajdusek DC (1985) Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Neurology 35:193-198
28. Garruto RM, Yase Y (1986) Neurodegenerative disorders of the western Pacific: the search for mechanisms of pathogenesis. Trends Neurosci 9:368-374
29. Good PF, Hsu A, Werner P, Perl DP, Olanow CW (1998) Protein nitration in Parkinson's disease. J Neuropathol Exp Neurol 57:338-342
30. Good PF, Olanow CW, Perl DP (1992a) Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: A LAMMA study. Brain Res 593:343-346
31. Good PF, Perl DP, Bierer LM, Schmeidler J (1992b) Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study. Ann Neurol 31: 286-292
32. Gutteridge JM, Quinlan GJ, Clark I, Halliwell B (1985) Aluminum salts accelerate peroxidation of membrane lipids stimulated by iron salts. Biochim Biophys Acta 835:441-447
33. Hirano A, Arumugasamy N, Zimmerman HM (1967) Amyotrophic lateral sclerosis. A comparison of Guam and classical cases. Arch Neurol 16:357-363
34. Hirano A, Dembitzer HM, Kurland LT, Zimmerman HM (1968) The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and "rod-like" structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism-dementia complex. J Neuropathol Exp Neurol 27:167-182
35. Hirano A, Kurland LT, Krooth RS, Lessell S (1961a) Parkinsonism-dementia complex, an endemic disease on the island of Guam I. Clinical features. Brain 84:642-661
36. Hirano A, Malamud N, Kurland LT (1961b) Parkinsonism-dementia complex, an endemic disease on the island of Guam II. Pathological features. Brain 84:662-679
37. Hirano A, Zimmerman HM (1962) Alzheimer's neurofibrillary changes. A topographic study. Neurology 7: 227-242
38. Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J Neurochem 56:446-451
39. Huang Y, Herman MM, Liu J, Katsetos CD, Wills MR, Savory J (1997) Neurofibrillary lesions in experimental aluminum-induced encephalopathy and Alzheimer's disease share immunoreactivity for amyloid precursor protein, A beta, alpha 1-antichymotrypsin and ubiquitin-protein conjugates. Brain Res 771: 213-220
40. Itoh N, Ishiguro K, Arai H, Kokubo Y, Sasaki R, Narita Y, Kuzuhara S (2003) Biochemical and ultrastructural study of neurofibrillary tangles in amyotrophic lateral sclerosis/parkinsonism-dementia complex in the Kii peninsula of Japan. J Neuropathol Exp Neurol 62:791-798
41. Jellinger K, Kienzl E, Rumpelmair G, Riederer P, Stachelberger H, Ben-Shachar D, Youdim MBH (1992) Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis. J Neurochem 59:1168-1171
42. Jenner P, Olanow CW (1996) Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47: S161-S170
43. Klatzo I, Wisniewski H, Streicher E (1965) Experimental production of neurofibrillary pathology: I. Light microscopic observations. J Neuropathol Exp Neurol 24:187-199
44. Koerner DR (1952) Amyotrophic lateral sclerosis on Guam: a clinical study and review of the literature. Ann Intern Med 37:1204-1220
45. Kokubo Y, Kuzuhara S (2004) Neurofibrillary tangles in ALS and Parkinsonism-dementia complex focus in Kii, Japan. Neurology 63:2399-2401
46. Kuhn LC (1999) Iron overload: molecular clues to its cause. Trends Biochem Sci 24:164-166
47. Kurland LT (1958) Epidemiology: incidence, geographic distribution and genetic considerations. In: Pathogenesis and Treatment of Parkinsonism. Field W (ed) Charles C. Thomas Publisher, p 5-43
48. Kurland LT, Mulder DW (1954) Epidemiologic investigations of amyotrophic lateral sclerosis. 1. Preliminary report on geographic distribution, with special reference to the Mariana Islands, including clinical and pathologic observations. Neurology 4:355-378, 438-448
49. Kurland LT, Mulder DW, Sayre GP, Lambert E, Hutson W, Iriarte LG, Imus HA (1956) Amyotrophic lateral sclerosis in the Marianas Islands. Arch Neurol Psych 75:435-441
50. Kuzuhara S, Kokubo Y (2005) Atypical parkinsonism of Japan: amyotrophic lateral sclerosis-parkinsonism-dementia complex of the Kii peninsula of Japan (Muro disease): an update. Mov Disord 20 Suppl 12: S108-S113
51. Kuzuhara S, Kokubo Y, Sasaki R, Narita Y, Yabana T, Hasegawa M, Iwatsubo T (2001) Familial amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Kii Peninsula of Japan: clinical and neuropathological study and tau analysis. Ann Neurol 49:501-511
52. Landsberg JP, McDonald B, Watt F (1992) Absence of aluminium in neuritic plaque cores in Alzheimer's disease. Nature 360:65-68
53. Linton RW, Bryan SR, Cox XB, Griffis DP, Shelburne JD, Fiori CE, Garruto RM (1987) Digital imaging studies of aluminum and calcium in neurofibrillary tangle-bearing neurons using SIMS (secondary ion mass spectrometry). Trace Elements Med 4:99-104
54. Malamud N, Hirano A, Kurland LT (1961) Pathoanatomic changes in amyotrophic lateral sclerosis on Guam. Neurology 5:401-414
55. Martin RB (1986) The chemistry of aluminum as related to biology and medicine. Clin Chem 32:1797-1806
56. Martyn CN, Coggon DN, Inskip H, Lacey RF, Young WF (1997) Aluminum concentrations in drinking water and risk of Alzheimer's disease. Epidemiology 8:281-286
57. McLachlan DR, McLachlan CD, Krishnan B, Krishnan SS, Dalton AJ, Steele JC (1989) Aluminum and calcium in soil and food from Guam, Palau and Jamaica: implications for amyotrophic lateral sclerosis and parkinsonism-dementia sysndromes of Guam. Env Geochem Health 11:45-53
58. Miller WR, Sanzolone RF (2003) Investigation of the possible connection of rock and soil geochemistry to the occurrence of high rates of neurodegenerative diseases on Guam and a hypothesis for the cause of the diseases. U.S. Department of the Interior, U.S. Geological Survey, Denver, CO, p 1-44
59. Miura K (1911) Amyotrophische lateralsklerose unter dem blide von sog. bulbarparalyse. Neurol Jap 10:366-369
60. Moalem S, Percy ME, Kruck TPA, Gelbart RR (2002) Epidemic pathogenic selection: an explanation for hereditary hemochromotosis? Med Hypotheses 59:325-329
61. Mura C, Le Gac G, Raguenes O, Mercier AY, Le Guen A, Ferec C (2000) Relation between HFE mutations and mild iron-overload expression. Mol Genet Metab 69:295-301
62. Murayama H, Shin RW, Higuchi J, Shibuya S, Muramoto T, Kitamoto T (1999) Interaction of aluminum with PHFtau in Alzheimer's disease neurofibrillary degeneration evidenced by desferrioxamine-assisted chelating autoclave method. Am J Pathol 155:877-885
63. Olanow CW Drayer B (1987) Brain iron: MRI studies in Parkinson syndrome. In: Recent Developments in Parkinson's Disease, Volume 2. Fahn S, Marsden CD, Calne DB, Goldstein M (eds) MacMillan Healthcare, p 135-143
64. Olanow CW, Perl DP (1994) Free radicals and neurodegeneration. Trends Neurosci 17:193-194
65. Parkinson J (1955) An essay on the shaking palsy. London. 1817. In: Reproduced in: James Parkinson (1755-1824). Critchley M (ed) MacMillan, p 145-218
66. Perez-Tur J, Buee L, Morris HR, Waring SC, Onstead L, Wavrant-De Vrieze F, Crook R, Buee-Scherrer V, Hof PR, Petersen RC, McGeer PL, Delacourte A, Hutton M, Siddique T, Ashkog JE, Hardy J, Steele JC (1999) Neurodegenerative diseases of Guam: analysis of tau. Neurology 53:411-413
67. Pert DP, Brody AR (1980) Alzheimer's Disease: X-ray spectrographic evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science 208:297-299
68. Perl DP, Gajdusek DC, Garruto RM, Yanagihara RT, Gibbs CJ Jr. (1982) Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Science 217:1053-1055
69. Perl DP, Munoz-Garcia D, Good PF, Pendlebury WW (1986) Calculation of intracellular aluminum concentration in neurofibrillary tangle (NFT)-bearing and NFT-free hippocampal neurons of ALS/parkinsonism dementia of Guam using laser microprobe analysis. J Neuropathol Exp Neurol 45:379
70. Perry G, Sayre LM, Atwood CS, Castellani RJ, Cash AD, Rottkamp CA, Smith MA (2002) The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs 16: 339-352
71. Piccardo P, Yanagihara R, Garruto RM, Gibbs CJ Jr., Gajdusek DC (1988) Histochemical and X-ray microanalytical localization of aluminum in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Acta Neuropathol 77:1-4
72. Plato CC, Cruz MT, Kurland LT (1969) Amyotrophic lateral sclerosis/ parkinsonism-dementia complex of Guam: further genetic investigations. Am J Hum Gen 21:133-141
73. Plato CC, Reed DM, Elizan TS, Kurland LT (1967) Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. IV. Familial and genetic investigations. Amer J Hum Gen 19:617-632
74. Poolsup N, Li Wan Po A, Knight TL (2000) Pharmacogenetics and psychopharmacotherapy. J Clin Pharm Ther 25:197-220
75. Poorkaj P, Tsuang D, Wijsman E, Steinbart E, Garruto RM, Craig UK, Chapman NH, Anderson L, Bird TD, Plato CC, Perl DP, Weiderholt W, Galasko D, Schellenberg GD (2001) TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam. Arch Neurol 58:1871-8
76. Purohit DP, Perl DP, Steele JC (1992) ALS/parkinsonism dementia-complex among Filipino migrants to Guam: report of two cases with parkinsonian features. J Neuropathol Exp Neurol 51:323
77. Rao JK, Katsetos CD, Herman MM, Savory J (1998) Experimental aluminum encephalomyelopathy. Relationship to human neurodegenerative disease. Clin Lab Med 18:687-698
78. Roden DM (2001) Principles in pharmacogenetics. Epilepsia 42 Suppl 5:44-48
79. Rondeau V (2002) A review of epidemiologic studies on aluminum and silica in relation to Alzheimer's disease and associated disorders. Rev Environ Health 17:107-121
80. Savory J, Huang Y, Herman MM, Reyes MR, Wills MR (1995) Tau inummoreactivity associated with aluminum maltolate-induced neurofibrillary degeneration in rabbits. Brain Res 669:325-329
81. Shankar SK, Yanagihara R, Garruto RM, Grundke-Iqbal I, Kosik KS, Gajdusek DC (1989) Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Ann Neurol 25:146-151
82. Shiraki H, Yase Y (1991) Amyotrophic lateral sclerosis and parkinsonism-dementia in the Kii Peninsula: comparison with the same disorders in Guam and with Alzheimer's disease. In: Handbook of Clinical Neurology, Vol 15 (59), Diseases of the Motor System. deJung JMBV (ed) Elsevier Scientific Publishing, p 273-300
83. Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MB (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 56:978-982
84. Spencer PS, Palmer VS, Ludolph AC (2005) On the decline and etiology of high-incidence motor system disease in West Papua (southwest New Guinea). Mov Disord 20 Suppl 12:S119-S126
85. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha synuclem in Lewy bodies. Nature 388:232-233
86. Stern AJ, Perl DP, Munoz-Garcia D, Good PF, Abraham C, Selkoe DJ (1986) Investigation of silicon and aluminum content in isolated plaque cores by laser microprobe mass analysis (LAMMA). 45:361
87. Terry RD, Pena C (1965) Experimental production of neurofibrillary pathology: Electron microscopy, phosphate histochemistry and electron probe analysis. J Neuropathol Exp Neurol 24:200-210
88. Thorburn D, Curry G, Spooner R, Spence E, Oien K, Halls D, Fox R, McCruden EA, MacSween RN, Mills PR (2002) The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 50:248-252
89. Torres J, Iriarte LL, Kurland LT (1957) Amyotrophic lateral sclerosis among Guamanians in California. Calif Med 4:385-388
90. Wisniewski K, Jervis GA, Moretz RC, Wisniewski HM (1979) Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia. Ann Neurol 5:288-294
91. Worwood M (2005) Inherited iron loading: genetic testing in diagnosis and management. Blood Rev 19:69-88
92. Yanagihara RT, Garruto RM, Gajdusek DC (1983) Epidemiological surveillance of amyotrophic lateral sclerosis and parkinsonism-dementia in the Commonwealth of the Northern Mariana Islands. Ann Neurol 13:79-86
93. Yase Y (1972) The pathogenesis of amyotrophic lateral sclerosis. Lancet 2:292-296
94. Youdim MB, Ben Shachar D, Riederer P (1989) Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? Acta Neurol Scand Suppl 126:47-54
95. Zecca L, Tampellini D, Gatti A, Crippa R, Eisner M, Sulzer D, Ito S, Fariello R, Gallorini M (2002) The neuromelanin of human substantia nigra and its interaction with metals. J Neural Transm 109:663-672
96. Zimmerman HM (1945) Monthly report to Medical Officer in Command. US Naval Medical Research Unit No 2